Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab – (Eye 30, 463 (March 2016))
Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab Eye 30, 463 (March 2016). doi:10.1038/eye.2015.259 Authors: L C Olmos, M S Sayed, A L Moraczewski, S J Gedde, P J Rosenfeld, W Shi, W J Feuer & R K Lee
Visual outcomes and ocular morbidity of patients with uveitis referred to a tertiary center during first year of follow-up – (Eye 30, 473 (March 2016))
Visual outcomes and ocular morbidity of patients with uveitis referred to a tertiary center during first year of follow-up Eye 30, 473 (March 2016). doi:10.1038/eye.2015.269 Authors: F Groen, W Ramdas, J de Hoog, J R Vingerling & A Rothova
Persistent subfoveolar fluid following retinal detachment surgery: an SD-OCT guided study on the incidence, aetiological associations, and natural history – (Eye 30, 481 (March 2016))
Persistent subfoveolar fluid following retinal detachment surgery: an SD-OCT guided study on the incidence, aetiological associations, and natural history Eye 30, 481 (March 2016). doi:10.1038/eye.2015.270 Authors: J J L Tee, M Veckeneer & D A Laidlaw
A rare penetrant TIMP3 mutation confers relatively late onset choroidal neovascularisation which can mimic age-related macular degeneration – (Eye 30, 488 (March 2016))
A rare penetrant TIMP3 mutation confers relatively late onset choroidal neovascularisation which can mimic age-related macular degeneration Eye 30, 488 (March 2016). doi:10.1038/eye.2015.204 Authors: A Warwick, J Gibson, R Sood & A Lotery
‘Toy’ laser macular burns in children: 12-month update – (Eye 30, 492 (March 2016))
‘Toy’ laser macular burns in children: 12-month update Eye 30, 492 (March 2016). doi:10.1038/eye.2015.222 Authors: N Raoof, J O’Hagan, N Pawlowska & F Quhill